84 filings
Page 3 of 5
EFFECT
jhgg3vmaj
23 Sep 22
Notice of effectiveness
12:15am
CORRESP
fv61zpzgmzhjs
20 Sep 22
Correspondence with SEC
12:00am
UPLOAD
t7rnb
19 Sep 22
Letter from SEC
12:00am
8-K
lmjx nyr3cvmtdl
15 Aug 22
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides
4:19pm
424B5
7zgcfbf 1pc
25 Jul 22
Prospectus supplement for primary offering
4:26pm
8-K
49r6haulg7k 0akqc
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
EFFECT
0w2giz2yebjtjh3
12 Jul 22
Notice of effectiveness
12:15am
S-3
5tzqfw
1 Jul 22
Shelf registration
8:46am
8-K
6zehtvs e7h8w
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
dmrnmpgazpmi0re7cu
11 May 22
Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
7:11am
DEFA14A
zke5gm
25 Apr 22
Additional proxy soliciting materials
4:09pm
DEF 14A
crhzs n8la
25 Apr 22
Definitive proxy
4:06pm
8-K
2gaq4ccz66vas 32
17 Mar 22
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
7:17am
S-8
ud7w9qh 70fvnn1o78
16 Mar 22
Registration of securities for employees
4:20pm
10-K
xouumntli 7w2uuuwg
16 Mar 22
Annual report
4:05pm
8-K
qrccf28d1k7
16 Nov 21
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update
6:05am